Drott continues to concentrate its business

Drott continues to concentrate its business - divestments outside Sweden - acquisitions in Stockholm region Drott has sold two properties outside Sweden for SEK 315 million, generating a capital gain of SEK 90 million. The sales price exceeded the estimated market value at December 31, 2001 and corresponds to a yield of 8.3 percent based on current leases. Location Sold properties Rentable floor Takeover space, sq. m. Bonn (Germany) Flur 63 N 14 (hotel) 14 279 Oct 2001 Brussels (Belgium) Europe House (offices) 4 319 Aug 2001 Total 18 598 The capital gain will be included in third-quarter earnings (Drott's nine-month report will be published on October 26, 2001). The divestment of Drott's two remaining properties outside Sweden - a fashion center in Düsseldorf and a development site in Brussels - is also under way. In addition, Drott has acquired the remaining 50 percent of the Medicinaren 19 property ("Novum"), comprising a total of 19,300 square meters of floor space at Huddinge Hospital, south of Stockholm. Drott is paying the equivalent of SEK 347 million for this half of the property. Based on current leases, the purchase price corresponds to a yield of slightly more than 9 percent. The tenants are about 20 healthcare and research institutions, including Astra Pain Control, Kari Bio and the Karolinska Institute. The takeover date was October 1, 2001. Drott AB (publ) Further information: Mats Mared, President (Tel: +46-8-545 83 010) ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2001/10/15/20011015BIT00850/bit0001.doc http://www.waymaker.net/bitonline/2001/10/15/20011015BIT00850/bit0001.pdf